0001140361-18-035271.txt : 20180802
0001140361-18-035271.hdr.sgml : 20180802
20180802195452
ACCESSION NUMBER: 0001140361-18-035271
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180731
FILED AS OF DATE: 20180802
DATE AS OF CHANGE: 20180802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASEY MICHAEL D
CENTRAL INDEX KEY: 0001190435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19720
FILM NUMBER: 18990100
MAIL ADDRESS:
STREET 1: ALLOS THERAPEUTICS, INC.
STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABAXIS INC
CENTRAL INDEX KEY: 0000881890
STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829]
IRS NUMBER: 770213001
STATE OF INCORPORATION: CA
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 3240 WHIPPLE
STREET 2: ROAD
CITY: UNION CITY
STATE: CA
ZIP: 94587
BUSINESS PHONE: (510) 675-6500
MAIL ADDRESS:
STREET 1: 3240 WHIPPLE
STREET 2: ROAD
CITY: UNION CITY
STATE: CA
ZIP: 94587
4
1
doc1.xml
FORM 4
X0306
4
2018-07-31
1
0000881890
ABAXIS INC
ABAX
0001190435
CASEY MICHAEL D
C/O ABAXIS, INC.
3240 WHIPPLE ROAD
UNION CITY
CA
94587
1
0
0
0
Common Stock
2018-07-31
4
D
0
29200
D
0
D
Restricted Stock Units
0
2018-07-31
4
D
0
5500
D
Common Stock
0
0
D
Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated May 15, 2018, by and among Abaxis, Inc., a California corporation (the "Issuer"), Zoetis Inc., a Delaware corporation ("Parent"), and Zeus Merger Sub, Inc., a California corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), on July 31, 2018, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and an indirect wholly owned subsidiary of Parent. In connection with the Merger, these shares were cancelled and converted into the right to receive $83.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration").
Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards.
Not applicable.
/s/ Michael D. Casey
2018-08-02